Heterogeneity in relaxation of different sized porcine coronary arteries to nitrovasodilators: role of PKG and MYPT1
- 288 Downloads
The present study was to determine the role of the type I isoform of cGMP-dependent protein kinase (PKG I) and its downstream effector myosin phosphatase target subunit 1 (MYPT1) in the responses of different sized coronary arteries to nitrovasodilators. Relaxations of isolated porcine coronary arteries were determined by isometric tension recording technique. Protein levels of PKG I and its effectors were analyzed by Western blotting. The activities of PKG I and MYPT1 were studied by analyzing phosphorylation of vasodilator-stimulated phosphoprotein (VASP) and MYPT1, respectively. Nitroglycerin, DETA NONOate, and 8-Br-cGMP caused greater relaxations in large than in small coronary arteries. Relaxations were attenuated to a greater extent by Rp-8-Br-PET-cGMPS (a PKG inhibitor) in large vs. small arteries. The expressions of PKG I and MYPT1 in large arteries were more abundant than in small arteries. DETA NONOate stimulated phosphorylation of VASP at Ser239 and inhibited phosphorylation of MYPT1 at Thr853 to a greater extent in large than in small arteries. A suppressed phosphorylation of MYPT1 at Thr853 was caused by 8-Br-cGMP in large but not small arteries, which was inhibited by Rp-8-Br-PET-cGMPS. These results suggest that the greater responsiveness of large coronary arteries to nitrovasodilators result in part from greater activities of PKG I and MYPT1. Dysfunction in nitric oxide signaling is implicated in the vulnerability of large coronary arteries to certain disorders such as atherosclerosis and spasm. Augmentation of PKG I–MYPT1 signaling may be of therapeutic benefit for combating these events.
KeywordsCoronary artery Nitric oxide Cyclic guanosine monophosphate Protein kinase G Vasodilatation
This study was supported in part by the National Natural Science Foundation of China, Grant #30870938, #30900511, and #81001433.
Conflict of interest
The authors state no conflict of interest.
- 2.Biel M, Altenhofen W, Hullin R, Ludwig J, Freichel M, Flockerzi V, Dascal N, Kaupp UB, Hofmann F (1993) Primary structure and functional expression of a cyclic nucleotide-gated channel from rabbit aorta. FEBS Lett 23(329):13413–13418Google Scholar
- 3.Bowles DK, Hu Q, Laughlin MH, Sturek M (1997) Heterogeneity of L-type calcium current density in coronary smooth muscle. Am J Physiol Heart Circ Physiol 273:H2083–H2089Google Scholar
- 6.Cheng KT, Chan FL, Huang Y, Chan WY, Yao X (2003). Expression of olfactory-type cyclic nucleotide-gated channel (CNGA2) in vascular tissues. Histochem Cell Biol. 2003 Dec;120(6):475–481Google Scholar
- 15.Gao Y, Portugal AD, Negash S, Zhou W, Longo LD, Raj JU (2007) Role of Rho kinases in PKG-mediated relaxation of pulmonary arteries of fetal lambs exposed to chronic high altitude hypoxia. Am J Physiol Lung Cell Mol Physiol 272:L678–L684Google Scholar
- 33.Makarova AM, Lebedeva TV, Nassar T, Higazi AA, Xue J, Carinato ME, Bdeir K, Cines DB, Stepanova V (2011) Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase. J Biol Chem 286:23044–23053PubMedCrossRefGoogle Scholar
- 40.Sellke FW, Myers PR, Bates JN, Harrison DG (1990) Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin. Am J Physiol Heart Circ Physiol 258:H515–H520Google Scholar
- 41.Smolenski A, Bachmann C, Reinhard K, Hönig-Liedl P, Jarchau T, Hoschuetzky H, Walter U (1998) Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J Biol Chem 273:20029–20035PubMedCrossRefGoogle Scholar
- 46.Zhang J, Somers M, Cobb FR (1993) Heterogeneous effects of nitroglycerin on the conductance and resistance coronary arterial vasculature. Am J Physiol Heart Circ Physiol 264:H1960–H1968Google Scholar